Intravenous ibandronate injections in postmenopausal women with osteoporosis: One-year results from the dosing intravenous administration study-Reference-Cited by-同舟云学术

Intravenous ibandronate injections in postmenopausal women with osteoporosis: One-year results from the dosing intravenous administration study

Published:2006 Issue:6 Volume:54 Page:1838-1846
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis Rheum

Author:

Delmas Pierre D.,Adami Silvano,Strugala Cezary,Stakkestad Jacob A.,Reginster Jean-Yves,Felsenberg Dieter,Christiansen Claus,Civitelli Roberto,Drezner Marc K.,Recker Robert R.,Bolognese Michael,Hughes Claire,Masanauskaite Daiva,Ward Penelope,Sambrook Philip,Reid David M.

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Reference27 articles.

1. Effects of Oral Ibandronate Administered Daily or Intermittently on Fracture Risk in Postmenopausal Osteoporosis

2. Daily and intermittent oral ibandronate normalize bone turnover and provide significant reduction in vertebral fracture risk: results from the BONE study

3. Randomized Trial of the Effects of Risedronate on Vertebral Fractures in Women with Established Postmenopausal Osteoporosis

4. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures

5. Effects of Risedronate Treatment on Vertebral and Nonvertebral Fractures in Women With Postmenopausal OsteoporosisA Randomized Controlled Trial

Cited by 212 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bisphosphonate alternative regimens for the prevention of osteoporotic fragility fractures: BLAST-OFF, a mixed-methods study;HEALTH TECHNOL ASSES;2024

2. The effectiveness of ibandronate in reducing the risk of nonvertebral fractures in women with osteoporosis: systematic review and meta-analysis of observational studies;International Journal of Clinical Pharmacy;2023-12-19

3. Antiresorptive Drugs’ Role in Management of Postmenopausal Osteoporosis;Endocrinology;2023-12-09

4. Insights into the Mechanism of Osteoporosis and the Available Treatment Options;Current Pharmaceutical Biotechnology;2023-11-02

5. Combined and sequential therapies with anabolic and antiresorptive drugs in the management of patients with postmenopausal osteoporosis;International Journal of Bone Fragility;2023-06-01